Gustave Roussy Research Platforms

Gustave Roussy has arranged that each of its research departments provides technical resources in common, the benefits of which are shared between all of its component research units. This mutual arrangement encourages interactions between departments and continuity within the research process. 

These platforms are brought together within the UMS AMMICa (CNRS UMS 3655 / Inserm US 23):

Treatment and care

In addition to specific cancer treatments, care referred to as supportive is advocated to ensure that Gustave Roussy patients receive an overall management and the best possible quality of life possible.

The quality of life of patients can be changed not only by their illness, but also by secondary effects and as a result of treatment sequellae. This is why at Gustave Roussy, supportive care is an integral part of management from the onset of treatment and sometimes long after it has ended. It focuses particularly on:

Lab members

• Leaders
  Isabelle PLO-AZEVEDO (DR2 INSERM), Hana RASLOVA (DR2 INSERM)
• Researchers
  Isabelle GODIN (DR2 CNRS), William VAINCHENKER (DRE INSERM), Najet DEBILI (DRE CNRS), Jean-Luc VILLEVAL (DRE INSERM), Monika WITTNER (CR1 CNRS), Antonio DI STEFANO (CRCN INSERM), Caroline MARTY (CRCN INSERM) ), Iléana ANTONY-DEBRE (CRCN INSERM)
• Clinicians / biologists
  Rémi FAVIER (PH APHP, Christine BELLANNE (MCU-PH / Interface INSERM), Florence PASQUIER (PH IGR), Christophe MARZAC (PH IGR), Jean-Baptiste MICOL (PH IGR)
• Technicians

Major publications

• Toppaldoddi KR, da Costa Cacemiro M, Bluteau O, Panneau-Schmaltz B, Pioch A, Muller D, Villeval JL, Raslova H, Constantinescu SN, Plo I, Vainchenker W, Marty C. Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice. Oncogene. 2019 Mar;38(10):1651-1660.

Demande de second avis médical - Tumeur du cerveau

Pour effectuer une demande de second avis médical, merci de nous adresser les éléments suivants :

• Coordonnées du patient : Nom, prénom, adresse postale et adresse e-mail
• Coordonnées du médecin traitant ou du médecin adressant la demande : Nom, prénom, adresse postale et adresse e-mail. L'avis médical sera adressé à ce médecin.
• Courrier médical de synthèse du dossier ou dossier complet
• Compte-rendu histo-pathologique (diagnostic de la maladie)

En précisant :